Salivary Gland Tumor Clinical Trial
Official title:
Immune Biomarker Study for Salivary Gland Carcinoma
Aims of this study are analyses of tumor metabolome, tumor transcriptome and tumor proteome as well as of the immune infiltration, separated by histological entity. These data will subsequently be compared with the with the detailed immune status determined in the patient's peripheral blood and saliva using machine learning techniques, among others, to create a biomarker cluster for salivary gland tumors. These can be used in clinical routine. In addition, the investigators would like to study a subset of patients from freshly resected tumor organoids from freshly resected tumor tissue according to already established methods in order to mechanistic investigations of prognostic parameters.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04970875 -
Partial Modified Blair Incision on Benign Tumor Parotidectomy Scar's Characteristics
|
||
| Completed |
NCT03602079 -
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT05581979 -
PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers
|
||
| Active, not recruiting |
NCT04249947 -
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)
|
Phase 1 | |
| Completed |
NCT06034782 -
Diagnostic Accuracy of Fine Needle Aspiration in Patients With Salivary Gland Tumors.
|
||
| Recruiting |
NCT04452162 -
Physiologic MR Imaging of Salivary Gland Tumors
|
N/A |